The effect of tepid amino acid-enriched induction cardioplegia on the outcome of infants undergoing cardiac surgery

Perfusion (United Kingdom)

Volumn 27, Issue 4, 2012, Pages 338-344

  Suominen, P K ^a   Keski Nisula, J ^a   Tynkkynen, P ^a   Kantoluoto, S ^a   Olkkola, K T ^b   Mildh, L ^c  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c Meilahti Hospital   (Finland)

Author keywords

children; congenital heart surgery; infants; inotrope score; myocardial protection; tepid cardioplegia

Indexed keywords

AMINO ACID; CARDIOPLEGIC AGENT; INOTROPIC AGENT; LACTIC ACID; TROPONIN T;

ARTICLE; ATRIOVENTRICULAR SEPTAL DEFECT; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; COLD BLOOD INDUCTION CARDIOPLEGIA; CONTROLLED STUDY; FALLOT TETRALOGY; FEMALE; GREAT VESSELS TRANSPOSITION; HEART MUSCLE INJURY; HEART PROTECTION; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INFANT; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OPEN HEART SURGERY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; TEPID AMINO ACID ENRICHED INDUCTION CARDIOPLEGIA; TREATMENT OUTCOME;

AMINO ACIDS; FEMALE; HEART ARREST, INDUCED; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES;

EID: 84862873043     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659112442237     Document Type: Article

References (19)

1. Allen BS. Pediatric myocardial protection: a cardioplegic strategy is the "solution". Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2004 ; 7: 141-154
2. Durandy Y. Pediatric myocardial protection. Curr Opin Cardiol. 2008 ; 23: 85-90
3. Rosenkranz ER, Buckberg GD, Laks H, et al. Warm induction of cardioplegia with glutamate-enriched blood in coronary patients with cardiogenic shock who are dependent on inotropic drugs and intra-aortic balloon support. J Thorac Cardiovasc Surg. 1983 ; 86: 507-518
4. Kronon M, Allen BS, Bolling KS, et al. The role of cardioplegia induction temperature and amino acid enrichment in neonatal myocardial protection. Ann Thorac Surg. 2000 ; 70: 756-764
5. Ghomeshi HR, Sun J, Tian G, et al. Can stunned hearts be resuscitated? Evaluation of aspartate/glutamate secondary blood cardioplegia using magnetic resonance spectroscopy. Interact Cardiovasc Thorac Surg. 2009 ;:
6. Tseng EE, Brock MV, Lang MS, et al. Glutamate excitotoxicity mediates neuronal apoptosis after hypothermic circulatory arrest. Ann Thorac Surg. 2010 ; 89: 440-445
7. Kronon M, Allen BS, Raham SK, et al. Reducing postischemic reperfusion damage in neonates using a terminal warm substrate enriched blood cardioplegic repurfusate. Ann Thorac Surg. 2000 ; 70: 765-770
8. Wernovsky G, Wypij D, Jonas RA, et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. Circulation. 1995 ; 92: 2226-2235
9. Shore S, Nelson DP, Pearl JM, et al. Usefulness of corticosteroid therapy in decreasing epinephrine requirements in critically ill infants with congenital heart disease. Am J Cardiol. 2001 ; 88: 591-594
10. Ghomeshi HR, Tian G, Ye J, et al. Aspartate/glutamate-enriched blood does not improve myocardial energy metabolism during ischemia-reperfusion: a 31P magnetic resonance spectroscopic study in isolated pig hearts. J Thorac Cardiovasc Surg. 1997 ; 113: 1068-1077
11. Caputo M, Modi P, Imura H, et al. Cold blood versus cold crystalloid cardioplegia for repair of ventricular septal defects in pediatric cardiac surgery: a randomized controlled trial. Ann Thorac Surg. 2002 ; 74: 530-535
12. Modi P, Suleiman MS, Reeves B, et al. Myocardial metabolic changes during pediatric cardiac surgery: a randomized study of 3 cardioplegic techniques. J Thorac Cardiovasc Surg. 2004 ; 128: 67-75
13. Toyoda Y, Yamaguchi M, Yoshimura N, et al. Cardioprotective effects and the mechanism of terminal warm blood cardioplegia in pediatric cardiac surgery. J Thorac Cardiovasc Surg. 2003 ; 125: 1242-1251
14. Åmark K, Berggren H, Björk K, et al. Blood cardioplegia provides superior protection in infant cardiac surgery. Ann Thorac Surg. 2005 ; 80: 989-994
15. Mildh LH, Pettilä V, Sairanen HI, et al. Cardiac troponin T levels for risk stratification in pediatric open heart surgery. Ann Thorac Surg. 2006 ; 82: 1643-1648
16. Mallidi HR, Sever J, Tamariz M, et al. The short-term and long-term effects of warm or tepid cardioplegia. J Thorac Cardiovasc Surg. 2003 ; 125: 711-720
17. Sinha P, Zurakowski D, Jonas RA. Comparison of two cardioplegia solutions using thermodilution cardiac output in neonates and children. Ann Thorac Surg. 2008 ; 86: 1613-1619
18. Jonas RA, Wypij D, Roth SJ, et al. The influence of hemodilution on outcome after hypothermic cardiopulmonary bypass: results of randomized trial in children. J Thorac Cardiovasc Surg. 2003 ; 126: 1765-1774
19. du Plessis AJ, Jonas RA, Wypij D, et al. Perioperative effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg. 1997 ; 114: 991-1001